Ending the reign of short-acting β2-agonists in Australia?
Price, D., Jenkins, C., Hancock, K., Vella, R., Heraud, F., Le Cheng, P., Murray, R. B., Bosnic-Anticevich, S. Z., Botini,, F., Carter, V., Catanzariti, A., Doan, J., Kichkin, A., Le, T., Le Lievre, C. E., Lau, C. M., Novic, D., Pakos, J., Ranasinghe, K., Roussos, A., Samuel-King, J., Sharma, A., Willet, B., Bateman, E. D., Beekman, M., Stewart, D.
Demographic and Clinical Characteristics of Patients with Severe Asthma in the Asian Pacific Region: data from the International Severe Asthma Registry (ISAR)
Lyu, J., Rhee, C. K., Tran, T. N., Katial, R., Martin, N., Peters, M., Denton, E., Upham, J. W., Bardin, P. G., Cochrane,, B., Middleton, P. G., Reynolds, P. M., Perng, D. W., Wang, H., Sheu, C., Tsai, M., Wan-Chun Huang, E., Chien, Y., Hsu, J., Fu, P., Lin, C., Lin, S., Shen, S., Liu, S., Lee, K., Chiu, K., Lin, H., Lin, M., Chou, C., Salvi, S., Cho, Y. S., Yoo, K. H., Iwanaga, T., Tohda, Y., Fujimoto, H., Tanaka, H., Nogami, K., Sekiya, K., Matsunaga, M., Soichiro, H., Fujisawa, T., Nagano, T., Kobayashi, T., Oguma, T., Nishimura, Y., Murray, R. B., Bulathsinhala, L., Joshi, I., Eleangovan, N., Skinner, D., Carter, V., Price, C., Price, D.
Dupilumab sustains improvements in clinical efficacy and reductions in OCS use in patients with severe, OCS-dependent asthma: LIBERTY ASTHMA TRAVERSE study
Park, H. Y., Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Pandit-Abid, N., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
Ending the reign of short-acting β2-agonists in Australia?
Price, D., Jenkins, C., Hancock, K., Vella, R., Heraud, F., Le Cheng, P., Murray, R. B., Bosnic-Anticevich, S., Botini,, F., Carter, V., Catanzariti, A., Doan, J., Kichkin, A., Le, T., Le Lievre, C. E., Lau, C. M., Novic, D., Pakos, J., Ranasinghe, K., Roussos, A., Samuel-King, J., Sharma, A., Willet, B., Bateman, E. D.
The association of short acting β2-agonist overuse with asthma control and severe exacerbations: an Australian perspective
Price, D., Jenkins, C., Hancock, K., Hancock, K., Heraud, F., Le Cheng, P., Murray, R. B., Bosnic-Anticevich, S., Botini,, F., Carter, V., Catanzariti, A., Doan, J., Kichkin, A., Le, T., Le Lievre, C. E., Lau, C. M., Pakos, J., Ranasinghe, K., Roussos, A., Samuel-King, J., Sharma, A., Bateman, E. D.
Effect of stepping up to high-dose inhaled corticosteroids in patients with asthma: UK Database Study
Pavord, I. D., Tran, T. N., Jones, R., Nuevo, J., van den Berge, M., Brusselle, G., Menzies-Gow, A., Skinner, D., Carter, V., Kocks, J. W. H., Price, D.
The Journal of Allergy and Clinical Immunology: In Practice, vol. 11, no. 2, pp. 532-543
Biologic Responders and Super-responders in the International Severe Asthma Registry
Price, D.
2023 ATS International Conference
Contributions to Conferences: Abstracts
An observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma
Heatley, H., Bourdin, A., Menzies-Gow, A., Jackson, D. J., Maslova, E., Chapaneri, J., Skinner, D., Carter, V., Shi Kai Chan, J., Ariti, C., Haughney, J., Price, D.
Clinical recommendations for dry powder inhaler use in the management of COPD in primary care
Leving, M., Bosnic-Anticevich, S., van Cooten, J., Correia de Sousa, J., Cvetkovski, B., Dekhuijzen, R., Dijk, L., Garcia Pardo, M., Gardev, A., Gawlik, R., van der Ham, I., Janse, Y., Lavorini, F., Maricoto, T., Meijer, J., Metz, B., Price, D., Román-Rodríguez, M., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Usmani, O., Kocks, J.
npj Primary Care Respiratory Medicine, vol. 32, 59
Commencement of fixed dose ICS of varying particle size as a predictor of pneumonia in COPD patients
Price, D., Henley, W., Carter, V., Skinner, D., Vella, R., Papi, A., Fabbri, L. M., Kerstjens, H. A., Roche, N., Singh, D., Vogelmeier, C. F., Şen, E., Delfini Cançado, J. E., Kots, M., Nudo, E., Barile, S., Georges, G.
Systemic Corticosteroids in Asthma: A Call to Action From World Allergy Organization and Respiratory Effectiveness Group
Bleecker, E. R., Al-Ahmad, M., Bjermer, L., Caminati, M., Walter Canonica, G., Kaplan, A., Papadopoulos, N. G., Roche, N., Ryan, D., Tohda, Y., Price, D.
World Allergy Organization Journal, vol. 15, no. 12, 100726
Adrenal function recovery after durable OCS-sparing with benralizumab in the PONENTE study
Menzies-Gow, A., Gurnell, M., Heaney, L. G., Corren, J., Bel, E. H., Maspero, J., Harrison, T., Jackson, D. J., Price, D., Lugogo, N., Kreindler, J., Burden, A., de Giorgio-Miller, A., Faison, S., Padilla, K., Martin, U. J., Garcia Gil, E., PONENTE Study Group
European Respiratory Journal, vol. 60, no. 6, 2103226
Biomarker-defined clusters by level of Type 2 inflammatory involvement in severe asthma
Price, D., Burkill, S., Eileen, W., Wechsler, M. E., Denton, E., Tran, T. N., Martin, N., Katial, R., Barker, P., Maspero, J. F., Hew, M., Brusselle, G., Christoff, G., Sadatsafavi, M., Torres-Duque, C. A., Porsbjerg, C. M., Ulrik, C., Hansen, S., Altraja, A., Bourdin, A., Papadopoulos, N. G., Kostikas, K., Salvi, S., Costello, R. W., Puggioni, F., Iwanaga, T., Rhee, C. K., Al-Ahmad, M., Larenas-Linnemann, D., Fonseca, J. A., Cosio, B. G., Siyue, M. K., Kirenga, B., Sheu, C., Tsai, M., Mahboub, B., Busby, J., Heaney, L. G., Pfeffer, P. E., Patel, P. H., Hoyte, F. L., Liu, Y., Lyu, J., Goh, C., Uthaman, T., Henley, W., ISAR EMBER
European Respiratory Society (ERS) International Congress., 2814
Characterising the impact of sex on severe asthma (SA) in the UK Severe Asthma Registry (UKSAR)
Loewenthal, L., Busby, J., McDowell, R. D., Brown, T., Burhan, H., Chaudhuri, R., Dennison, P., Dodd, J. W., Doe, S., Faruqi, S., Gore, R., Idris, E., Jackson, D. J., Patel, M., Pantin, T., Pavord, I. D., Pfeffer, P. E., Price, D., Siddiqui, S., Heaney, L. G., Menzies-Gow, A.
European Respiratory Society (ERS) International Congress., 308
Commencement of fixed dose ICS of varying particle size as a predictor of pneumonia in COPD patients
Price, D., Henley, W., Carter, V., Skinner, D., Vella, R., Papi, A., Fabbri, L. M., Kerstjens, H. A., Roche, N., Singh, D., Vogelmeier, C. F., Şen, E., Delfini Cançado, J. E., Kots, M., Nudo, E., Barile, S., Georges, G.
European Respiratory Society (ERS) International Congress., pp. 1552
Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
Burkill, S., Porsbjerg, C. M., Bourdin, A., Tran, T. N., Martin, N., Katial, R., Barker, P., Wechsler, M. E., Maspero, J. F., Bosnic-Anticevich, S., Chung, L. P., Katsoulotos, G., Christoff, G., Popov, T. A., Sadatsafavi, M., Torres-Duque, C. A., Ulrik, C., Assing, K. D., Hansen, S., Altraja, A., Lehtimäki, L. A., Papadopoulos, N. G., Kostikas, K., Salvi, S., Costello, R. W., Puggioni, F., Iwanaga, T., Rhee, C. K., Al-Ahmad, M., Larenas-Linnemann, D., Fonseca, J. A., Amaral, R., Al-Lehebi, R., Perez de Llano, L., Kirenga, B., Tsai, M., Mahboub, B., Pfeffer, P. E., Henley, W., Liu, Y., Lyu, J., Goh, C., Uthaman, T., Price, D., ISAR IGNITE
European Respiratory Society (ERS) International Congress., 3305
Risk factors for corticosteroid- and antibiotic only-treated asthma attacks in the NOVELTY cohort
Couillard, S., Peterson, S., Bengtsson, T., van den Berge, M., Price, D., Beasley, R., Sadatsafavi, M., Janson, C., Papi, A., Belton, L., Fagerås, M., Müllerová, H., Pavord, I. D.
European Respiratory Society (ERS) International Congress., 2125
Effectiveness of initiating biologics in severe asthma patients with high steroid exposure
Chen, W., Tran, T. N., Sadatsafavi, M., Garcia Gil, E., Alacqua, M., Menzies-Gow, A., Heaney, L. G., Pfeffer, P. E., Maspero, J. F., Peters, M., Christoff, G., Bhutani, M., Torres-Duque, C. A., Ulrik, C., Altraja, A., Lehtimäki, L., Taillé, C., Papaioannou, A. I., Salvi, S., Costello, R. W., Canonica, G. W., Iwanaga, T., Al-Ahmad, M., Larenas-Linnemann, D., Kuna, P., Fonseca, J. A., Al-Lehebi, R., Siyue, M. K., Rhee, C. K., Perez de Llano, L., Jones, R. C., Perng, D. W., Eileen, W., Hoyte, F. L., Wong, N. C. B., Lyu, J., Ariti, C., Murray, R., Goh, C., Joshi, I., Eleangovan, N., Price, D., ISAR GLITTER Working Group
European Respiratory Society (ERS) International Congress., 3405
Patient-reported barriers to accepting a technological adherence package in the MAGNIFY trial.
Dickens, A. P., Halpin, D. M., Carter, V., Skinner, D., Beeh, K. M., Chalmers, J., Clark, A., Hannan, N., Kaplan, A., Kostikas, K., Pinnock, H., Roche, N., Usmani, O., van Boven, J. F., Mastoridis, P., Mezzi, K., Davis, S., Price, D.
European Respiratory Society (ERS) International Congress.
